According to the Newfoundland's largest health authority an internal review conducted into testing errors for cyclosporine at its biochemistry lab in St. John's states that executives were not given timely information about the testing.
Eastern Health CEO Vickie Kaminski said, "It is a serious breach of hospital policy. Those policies were made widely available and certainly staff know about it and that was not followed."
Reports also state that the analyzer was used without referring to a literature. Cyclosporine is a drug that is used for if the immune system is in jeopardy by disease or is due to an organ transplant.
Eastern Health stated that 212 patients had suffered the impact of errors and eight out of them have died.
No direct link has however been established by the Eastern Health between the testing problems and the deaths.
The result of the misreading of results can result in more dose being administered to a patient.
According to the review, one of the analyzers was under question on January 18 but not until February 12 it was clear that incorrect results was being given.
Good News USA
- Vodafone NZ’s new ‘Red Home’ packages will offer UFB and 150 TV channels
- Vodafone NZ’s full-year profit plunged by more than two-thirds to $56 million
- Vodafone adding 34 European countries to ‘AU$5 per day’ international roaming option
- Telstra launches its new ‘Every Day Connect Data Share Packages’
- Voyager signs “multimillion-dollar deal” with submarine cable group Hawaiki